Streamlining biologics technology transfer through integrated operational models
By bringing development, testing, and manufacturing teams together to work in parallel, technology transfer can be streamlined, eliminating the delays of passing tasks sequentially from one team to the next. Keeping development scientists actively involved during scale-up ensures their technical knowledge is immediately available to resolve unexpected issues on the floor. Combined with early analytical testing and predictive modeling, this approach confirms that a facility is fully ready for GMP production as soon as the process design is finalized, reducing project risks and commercialization delays.
By bringing development, testing, and manufacturing teams together to work in parallel, technology transfer can be streamlined, eliminating the delays of passing tasks sequentially from one team to the next. Keeping development scientists actively involved during scale-up ensures their technical knowledge is immediately available to resolve unexpected issues on the floor. Combined with early analytical testing and predictive modeling, this approach confirms that a facility is fully ready for GMP production as soon as the process design is finalized, reducing project risks and commercialization delays.
Related Content